Michel Tod

A Tumor Growth Inhibition Model for Low-Grade Glioma Treated with Chemotherapy or Radiotherapy

Benjamin Ribba, Gentian Kaloshi, Matthieu Peyre et al. · Clinical Cancer Research · 2012 · 139 citations · Full text

Medicine, Oncology, Pharmacology +16

CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial

Benoît You, Patrick Robelin, Michel Tod et al. · Clinical Cancer Research · 2020 · 132 citations

Medicine, Oncology, Pharmacology +13

Salvage Debridement, Antibiotics and Implant Retention (“DAIR”) With Local Injection of a Selected Cocktail of Bacteriophages: Is It an Option for an Elderly Patient With Relapsing Staphylococcus aureus Prosthetic-Joint Infection?

Tristan Ferry, Gilles Leboucher, Cindy Fèvre et al. · Open Forum Infectious Diseases · 2018 · 121 citations · Full text

Medicine, Surgery, Antimicrobial Pharmacotherapy +16

Validation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practice

Benoı̂t Blanchet, Bertrand Billemont, Julie Cramard et al. · Journal of Pharmaceutical and Biomedical Analysis · 2009 · 119 citations

Pharmacy, Pharmacokinetics, Pharmacology +7

Variability of Sorafenib Toxicity and Exposure over Time: A Pharmacokinetic/Pharmacodynamic Analysis

Pascaline Boudou‐Rouquette, Stanislas Ropert, Olivier Mir et al. · The Oncologist · 2012 · 104 citations · Full text

Medicine, Oncology, Pharmacology +17